To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19

Phase 2

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/08/027346
• Lead Sponsor: Shri Dhanwantry ayurevdic college and hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Asymptomatic to moderate cases registered in the Hospital, above 18 years of age of either gender, with COVID 2019 (Confirmed by Antigen test/ RT-PCR) quarantined at our hospital.

2. Participants who can take medicines orally

3. Patients willing to provide signed informed consent

Exclusion Criteria

1.Patients suffering from severe COVID-19 Disease as judged by a physician

2.Chronic, Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study

3.Patients who are likely to worsen or planed ICU admission or ventilator support due to any reason

4.Pregnancy and lactation

5.Participation in a drug interventional clinical drug trial of any nature in the three month period preceding onset of COVID-19

6.Participation in any other clinical trial of an experimental agent treatment for COVID-19

7. Patients on any kind of Ayurveda treatment or any other alternative and complementary medicinal systems such as Homeopathy, Unani, Siddha and in particular requiring oral therapy of any kind.

8.Physician decision that involvement in the study is not in the patient´s best interest.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Mean time for clinical recoveryTimepoint: 1.5th and 10th day

Secondary Outcome Measures

Name	Time	Method
Changes in Laboratory and Radiological parameters (RT-PCR, CBC, ESR, LFT, RFT, BS, CRP, D-dimer, Lipid profile, HRCT chest).Timepoint: 1st 5th and 10th day